Cargando…
Baicalin prevents pulmonary arterial remodeling in vivo via the AKT/ERK/NF-κB signaling pathways
Pulmonary arterial hypertension is a rapidly progressive and often fatal disease. As the pathogenesis of pulmonary arterial hypertension remains unclear, there is currently no good drug for pulmonary arterial hypertension and new therapy is desperately needed. This study investigated the effects and...
Autores principales: | Yan, Guosen, Wang, Jinxia, Yi, Tao, Cheng, Junfen, Guo, Haixu, He, Yuan, Shui, Xiaorong, Wu, Zeyong, Huang, Shian, Lei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831981/ https://www.ncbi.nlm.nih.gov/pubmed/31723406 http://dx.doi.org/10.1177/2045894019878599 |
Ejemplares similares
-
Quercetin Inhibits Pulmonary Arterial Endothelial Cell Transdifferentiation Possibly by Akt and Erk1/2 Pathways
por: Huang, Shian, et al.
Publicado: (2017) -
Heart-lung crosstalk in pulmonary arterial hypertension following myocardial infarction (Review)
por: Ye, Wenfeng, et al.
Publicado: (2020) -
Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-κB Pathway
por: Long, Yu, et al.
Publicado: (2020) -
Baicalin ameliorates APEC-induced intestinal injury in chicks by inhibiting the PI3K/AKT-mediated NF-κB signaling pathway
por: Cheng, Xinyi, et al.
Publicado: (2021) -
Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways
por: Shen, Bingyu, et al.
Publicado: (2023)